ClinicalTrials.gg
CompletedNCT07399379RACARUpdated Feb 10, 2026

Augmented Reality as Discharge Information for Hospitalized Cardiology Patients

An interventional study of Augmented reality app in Myocardial Infarction (MI), Pacemaker Implantation and Heart Failure, sponsored by Hospital Universitario Getafe. Completed at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-10.

Sponsored by Hospital Universitario Getafe · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Feb 2024, registered Jan 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
303
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 131 studies in Myocardial Infarction with a site in Spain — 19 open to participants now, 27 under way, 7 of them phase 3. Myocardial Infarction · Spain.

Enrollment
59th of 98
303 · median 445
Started
2024
with 4 others
No phase
29 of 131
5 open now
Registered
127th of 131
by date

Among the 131 studies in Myocardial Infarction with a site in Spain, this one is the 59th largest by enrollment of the 98 interventional ones that give a count, is one of 5 that started in 2024, is one of 29 with no phase, and was the 127th registered.

Myocardial Infarction

2,273 studies on the registry are indexed under Myocardial Infarction; 373 are open to participants now.

Browse Myocardial Infarction studies →

Open to participants now

19 of the 131 studies in Myocardial Infarction with a site in Spain are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 256 Myocardial Infarction studies recruiting now, 173 (68%) set no upper age limit and 25 (10%) stop at 75 or younger; 17 take children under 18; 27 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 131 studies in Myocardial Infarction with a site in Spain, or all of them as a file.
02

Study summary

The goal of this clinical trial is to find out whether a simple augmented reality tool provided at hospital discharge can improve patients' understanding of their care, adherence to treatment, and health outcomes, compared with the usual discharge information.

This study includes adult patients who are admitted to a cardiology department because of:

  • Ischaemic heart disease
  • Atrial fibrillation
  • Heart failure
  • Or who need a pacemaker implantation

The main questions this study aims to answer are:

  • Does providing augmented reality information at discharge improve patients' perceived quality of care?
  • Does it improve patients' adherence to their prescribed treatment?
  • Does it reduce major cardiovascular events such as hospital readmission, heart attack, stroke, or cardiovascular death?

Researchers will compare two groups of participants:

  • A control group, who will receive the usual medical discharge report.
  • An intervention group, who will receive the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application.

Participants will:

  • Receive their discharge information according to the group they are assigned to.
  • Use the augmented reality application if they are in the intervention group.
  • Be followed over time to assess treatment adherence, patient experience, and cardiovascular events.

This is a low-intervention, randomized, single-centre clinical trial conducted in Getafe, Madrid, Spain. Participation in this study does not involve taking any additional medication.

03

Conditions studied

  • Myocardial Infarction (MI)
  • Pacemaker Implantation
  • Heart Failure
  • Atrial Fibrillation (AF)

Keywords

  • Augmented reality
  • Acute Coronary Syndrome
  • Heart Failure
  • Pacemaker
  • PREM
  • Atrial Fibrillation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Participants must have access to a mobile device (such as a smartphone or tablet).
  • Participants must have been admitted to the Cardiology Department of Getafe University Hospital for ischemic heart disease, heart failure, atrial fibrillation, or pacemaker implantation.

Exclusion criteria

Exclusion Criteria:

  • No access to a mobile device.
  • Untreated visual or hearing impairments that prevent viewing or understanding the videos.
  • Inability to understand Spanish
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
303 participants (actual)

Study arms

  • Active comparator
    Intervention Group

    This group receives the usual medical discharge report plus an information card with a drawing and a QR code that gives access to an augmented reality application explaining their disease.

    Device: Augmented reality app

  • No intervention
    Control group

    This group receives the usual medical discharge report.

Interventions

  • DeviceAugmented reality app

    The card provided in addition to the usual medical discharge report is designed with a simple drawing that identifies each condition and a QR code. This code can be scanned from any mobile device using the device's camera. Once scanned, a 3D model of a heart or a stent (depending on the condition) appears on the device, showing movement, vibration, and sound as an example of augmented reality. The user can also access simple options through three buttons: 1. Video recorded by a cardiology professional: a brief and easy-to-understand explanation of the patient's condition, lasting approximately 2-3 minutes, provided by a hospital cardiology professional. 2. Treatment recommendations: a drop-down section with a table of discharge recommendations for the patient's condition, including lifestyle and dietary advice. 3. Warning signs: situations that the patient should pay attention to and seek medical advice if they occur.

06

What researchers measure

Primary outcomes

  1. PRIMARY OUTCOME: PREM and treatment adherence at one and six months

    To assess PREM (Patient-Reported Experience Measures) in the intervention group and in the control group at discharge and at follow-up.

    Time frame: Follow up at one and six months from enrollment

Secondary outcomes

  1. MACE at one and six months

    Data on major adverse cardiovascular events (MACE) will also be collected at one and six months from discharge in both groups. MACE include heart attack, stroke, cardiovascular-related hospital readmission, and cardiovascular death.

    Time frame: From enrollment at one and six months

07

Study locations

1 site
  • Hospital Universitario de Getafe
    Getafe, Madrid 28905, Spain
08

References and documents

Publications

  • Davies F. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Quarterly. 1989; 13: 319-40.
  • Lahanas V, Loukas C, Smailis N, Georgiou E. A novel augmented reality simulator for skills assessment in minimal invasive surgery. Surg Endosc. 2015 Aug;29(8):2224-34. doi: 10.1007/s00464-014-3930-y. Epub 2014 Oct 11. PubMed 25303925 ↗
  • Kang X, Azizian M, Wilson E, Wu K, Martin AD, Kane TD, Peters CA, Cleary K, Shekhar R. Stereoscopic augmented reality for laparoscopic surgery. Surg Endosc. 2014 Jul;28(7):2227-35. doi: 10.1007/s00464-014-3433-x. Epub 2014 Feb 1. PubMed 24488352 ↗
  • Barroso Osuna, J., & Cabero Almenara, J. (2016). Evaluación de objetos de aprendizaje en Realidad Aumentada: estudio piloto en el grado de Medicina. Enseñanza & Teaching: Revista Interuniversitaria De Didáctica, 34(2), 149-67. https://doi.org/10.14201/et2016342149167.
  • Almenara, J.C., Osuna, J.B., Puente, Á.P., et al. Realidad Aumentada para aumentar la formación en la enseñanza de la Medicina. Educ. Medica. Super. 2018; 32 (4): 1-14.

Individual participant data

Plan to share: No — Individual Participant Data will not be shared because the dataset contains sensitive patient health information, including medical history and follow-up outcomes. Sharing these data could risk patient confidentiality. All data will be handled according to current data protection regulations and only anonymized, aggregated results will be made publicly available.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in Dec 2025, 21 months.

Of 322 non-industry interventional studies with no phase under Myocardial Infarction, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's 21 months is below that.

Counting every sponsor, half of 355 studies reached it within 34 months; a quarter within 15 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 13, 2026
First posted
Feb 10, 2026
StartActual
Feb 23, 2024
Primary completionActual
Dec 16, 2025
CompletionActual
Dec 29, 2025
Last update
Feb 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07399379
Lead sponsor
Hospital Universitario Getafe
Responsible party
Sponsor
First posted
Feb 10, 2026
Start date
Feb 23, 2024
Primary completion
Dec 16, 2025
Completion
Dec 29, 2025
Last update
Feb 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion